Calcium supplementation and kidney stone risk in osteoporosis a systematic literature review
matology Consensus of osteoporosis to generate clinical practice recommenda-tions for rheumatologists.
Methods
As Rheumatology Consensus of osteoporo-a part of the Spanish Society of sis, performed to address the experts’ ques-a systematic literature review was tion in osteoporosis and the risk of nephro-on the use calcium supplements lithiasis. A protocol of the review was established and further advice from the complete obtained.
team of the Consensus was Search strategy
The tive studies were liographic databases (Table I). For this search strategies identi ed in the main by sensi-bib-purpose, an expert librarian collaborat-ed and checked the search strategies.The were screened as follows: Medline and following bibliographic databases Embase and from Controlled the Cochrane 1991 to 20th July 2010, 20thnual scienti c meetings of the July 2010. The abstracts of the an-Trials (CENTRAL) Central register up of to College the European League Against Rheuma-of Rheumatology (ACR) American and tism (EULAR) from 2008 to 2010 were also examined. There were no language limitations. All the retrieved references were end, reviewing the references of the included a managed hand search in Endnote was completed X.2. In the by studies, and all the publications or other information provided by the experts re-lated to the systematic review were also examined.
Selection criteria
The strategies were included if they met the studies retrieved by the above following patients pre-established criteria. of any osteoporosis studied oral calcium supplements (any kind of cause), and (all had to be diagnosed The they ages, had to both be taking sexes, preparation) other measured the likelihood of having renal treatments alone for or osteoporosis. associated with We colic and oxalate or calcium phosphate kidney stones (whether or not it caused renal which is an index that measures the risk
colic), the AP(CaOx) index, of developing kidney stones, changes in urinary phate, uric acid, oxalate uric pH), alka-sediment (uric calcium, phos-line verse events. We included in the search phosphatase (ALP) and other ad-for clinical trials (RCT) and cohort studies. systematic reviews randomised We excluded articles on cancer or other disease other than osteoporosis, animal and on calcitriol.
basic science studies, and studies Screening of studies, data collection and analysis
Two Martinez-Lopez) screened the titles and reviewers (G. Candelas and J.A. abstracts selection of process criteria the retrieved independently. articles This for sions. The two reviewers collected the was done in 20-minute ses-data from the studies included by using ad hoc All collection was double by article and standard forms.
independent. Both reviewers entered the data from the forms into spreadsheets. If, while doing this, the reviewers found any discrepancy between them, then a consensus the original article or by asking a third was reached by looking at researcher not ful l all the inclusion criteria or that (E. Loza). Articles that did had insuf cient data were excluded. To grade the quality, we used a modi ca-tion of the Oxford Centre for Evidence-based Medicine Levels of Evidence in its May 2001 update (13) including the following: RCT with homogeneity; 1b) individual 1a) systematic reviews of RCT with narrow con dence intervals; 1c) trials in which all patients get harm or none does; 2a) systematic reviews of cohort individual cohort study, or low quality studies with homogeneity; 2b) randomised controlled trials; 2c) “out-comes” research and ecological studies; 3a) systematic reviews of case-control studies with homogeneity; 3b) individ-ual and case-control study; 4) trol studies; and 5) expert opinion with-poor quality cohort and case-series case-con-out explicit critical appraisal, or based on physiology, bench research or “ rst principles”.
Evidence tables were produced. Meta-analysis enough was only planned among the included studies.
homogeneity was in present case 955
We estimated the incidence rate (IR) of nephrolitiasis or not it caused renal colic) due to cal-or urolithiasis (whether cium tient-years, with 95% con dence inter-supplementation per 1.000 pa-vals (95%CI) combining all studies.Results
The presented in Table I by speci c terms, result of the search strategies is and articles in total cause that in were Figure studied 1. We in found 46 to they had no abstract to review. Table II be by related title to or the abstract study, they detail or because seemed be-shows after the studies that were for exclusion. Finally, 10 studies were detailed review and the excluded reasons included (quality level 2a-b) and 2 cohort studies (Table III), of which 8 RCT (quality trieved. Table III shows the main char-level 2b-c), and their data re-acteristics of the included studies.
Related patients to tients), mostly were women with mean had the osteoporosis studies population, (>8.000 pa-all ages around 50–70 years. Daily supple-ments 120 mg up to 1.500 mg, and treatment intake of calcium varied from duration articles from 3 days to 3 years. Most strategies analysed mal serum and urinary markers of bone and all measured different the treatment abnor-metabolism asis cluded cases. Using and registered data from nephrolithi-all the in-nephrolitiasis or urolithiasis (whether or studies, the incidence rate of not it caused renal colic) due to calcium supplementation persons/year (95%CI 0.41–1.40).
was 0.75 per 1.000 Another author (quality level 2 b-c) (14) analysed the risk of nephrolithiasis with calcium supplements (625 mg/d) alone or No signi cant change0s were found in associated with estrogen therapy. urinary calcium, oxalate, or citrate com-pared urinary excretion of phosphate was sig-with baseline in any group. The ni cantly the ratio calcium/citrate and AP (CaOx) reduced in both groups, but did not change. There were no cases of nephrolithiasis.
In RCT a of vitamin D 800 IU/d and calcium sup-(quality double-blind level 1c) placebo-controlled (15), the effect plements 1.000 mg/d in combination or alone was analysed. No serious adverse
Ian Reid and colleagues1 did a systematic review...calcium supplementation, baseline concentration of 25...risk in women with postmenopausal osteoporosis ...
Current status of research on osteoporosis in COPD: a systematic review L....interventions in osteoporosis, bisphosphonates, calcium supplementation, vitamin D...
calcium as part of the 191 osteoporosis management...Can vitamin D supplementation reduce the risk of ...falls in older persons: a systematic review. ...
osteoporosis, as well as systematic reviews and meta-analyses of previously ...Other data support the effectiveness of calcium and vitamin D supplementation ...
Calcium and Disease Prevention Osteoporosis ...levels actually reduces kidney stone formation risk... calcium supplementation may be necessary to obtain...
Osteoporosis: the role of micronutrients1– 4 ...Calcium supplementation and increases in bone ...older adults: a systematic review and meta-...
Calcium supplementation was used in 26 trials (6...Discussion We conducted a systematic review and ...patients with osteoporosis and fracture risk [84]...
Guided by systematic reviews of evidence in ... osteoporosis, chronic kidney disease, liver ...A daily supplementation of 1,000 IU of vitamin ...
? Osteoporosis Osteoporosis means “porous bone,”...levels actually reduces kidney stone formation risk... calcium supplementation may be necessary to obtain...
Data Sources: We conducted a systematic search in...health and preventing osteoporosis and falls (1, ...Calcium plus vitamin D supplementation and the ...
热门文档